Fortrea

FTRE
21.6103.30% ( +0.690 )
Trading: Oct 14, 11:26:45 (EDT)

Current ValuationThe current P/E ratio is -23.35, below the reasonable range, cheaper than 87.47% of the time in the past 3 years, and the industry ranks 47/58, the industry Median -2.09.

-23.35xP/E
Stock price$20.92Earnings per share$-0.90

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-345.22x--$47.53B
CRLUSCharles River Laboratorie
-59.86x242.15%$14.27B
TEMUSTempus AI
-48.10x1.10%$12.24B
AVTRUSAvantor
-18.20x144.24%$10.52B
TXGUS10X Genomics
-124.51x107.10%$9.35B
BRKRUSBruker
-80.08x7.71%$8.56B
ABCLUSAbcellera Biologics
-24.82x36.29%$4.09B
ADPTUSAdaptive Biotechnologies
-63.18x39.25%$4.03B
FTREUSFortrea
-23.35x93.77%$1.99B
MRVIUSMaravai LifeSciences
-21.91x64.44%$1.70B
PSNLUSPersonalis
-15.79x18.68%$1.69B
AZTAUSAzenta
-13.50x177.69%$1.66B
ALMRUSAlamar Biosciences
-32.87x80.55%$1.63B
CYRXUSCryoport
-18.92x156.25%$858.50M
DNAUSGinkgo Bioworks
-2.72x35.20%$791.92M
CTKBUSCytek Biosciences
-8.63x33.98%$695.41M
OABIUSOmniAb
-15.44x35.96%$683.33M
PACBUSPacific Biosc California
-4.85x75.69%$637.20M
EVOUSEvotec SE
-2.09x382.97%$477.76M
TKNOUSAlpha Teknova
-26.32x5.80%$441.32M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.